Biosynex
A key partner for healthcare professionals
-
French laboratory
-
In-house products developed by our R&D team
-
A team of 50 sales representatives throughout France
-
Certified products
our products
Focus on
Urinary infection self-test
During a cystitis, bacterial proliferation can lead to the presence of certain cells and substances in the urine. For example, the immune system’s reaction to the bacteria may result in the presence of a large number of leukocytes in the urine.
Talking about us
In the press
-
12 June 2023BIOSYNEX acquiert PROCISEDX
We are pleased to announce the acquisition of the North American company ProciseDx! This acquisition strengthens our laboratory's presence in the United States, and represents a...
-
2 May 2023SEC CHEMBIO documents
Documents filed with the SEC. Acquisition of CHEMBIO DIAGNOSTICS:
-
15 March 2023
Biosynex and Chembio Diagnostics Announce Definitive Acquisition Agreement
Find out more about BIOSYNEX and CHEMBIO: • Project Merci – Schedule to tender offert statement under section 14(d)(1) or 13(e)(1) of the securities exchange...
-
17 January 2023Extension of the distribution agreement between Credo Diagnostics Biomedical Pte Ltd and BIOSYNEX S.A.
« BIOSYNEX and Credo Diagnostics have recently strengthened their collaboration by signing an exclusivity agreement for an extended territory including the United Kingdom. Thanks to...
-
4 January 2023Biosynex announces the acquisition of a 75% stake in Danish company Medkoncept AS
As part of its international development, BIOSYNEX announces that it has acquired a 75% majority stake,alongside the two founders, in MEDKONCEPT AS, a company based...
-
20 April 2022Biosynex has acquired Parakito
« Biosynex has acquired PARAKITO, operated by Hong-Kong based Evergreen Land LTD. The transaction includes assets and IP and the exclusive right to commercialize the...